MedPath

Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions.

Not Applicable
Conditions
Migraine
Registration Number
NCT03083860
Lead Sponsor
Brainmarc Ltd.
Brief Summary

Evaluation of migraine management mobile app combined with electrophysiological measurements for identification of migraine attack risk and beneficial preventive actions.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Diagnosed with migraine by a neurologist.
  • Male or Female, aged 18 -50 years.
  • Having 3-10 migraine attacks per month.
  • Able and willing to comply with all study requirements.
  • Having Android based smartphone
Exclusion Criteria
  • Diagnosed with chronic pain, neurological or psychiatric disorders.
  • Current or past use of anti-depressants.
  • A user of recreational or illicit drugs or has had a recent history of drug or alcohol abuse or dependence.
  • History of seizures.
  • Head injury with consciousness loss in the last three months.
  • Diagnosed as ADHD and/or use of Ritalin.
  • Hearing disorder and/or known eardrum impairment.
  • Having migraine attacks occurring only during the menstruation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Evaluation of correlation of attention-related electrophysiological changes and patients' migraine dynamics based at-home EEG measurements via mobile phone app.12 months

significant difference between interictal days and treictal days

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rambam MC

🇮🇱

Haifa, Israel

Rambam MC
🇮🇱Haifa, Israel
David Yarnitzki, MD, Prof.
Contact
972-47772605
© Copyright 2025. All Rights Reserved by MedPath